<DOC>
	<DOCNO>NCT02265159</DOCNO>
	<brief_summary>The investigator aim evaluate cancer control , genitourinary , rectal overall health-related quality life outcomes effectiveness focal therapy localise prostate cancer use High Intensity Focused Ultrasound ( HIFU ) .</brief_summary>
	<brief_title>Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound Treatment Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically proven prostate cancer transrectal transperineal template prostate biopsy Template biopsy : unilateral disease ( Gleason ≤4+3 ) bilateral disease : presence clinically significant cancer side ( Gleason ≤4+3 ) OR clinically insignificant disease burden &gt; 50 % biopsy core take side , OR bilateral clinically insignificant disease &lt; 50 % biopsy core positive one side dominant disease burden one side Stage T1T2cN0M0 disease , determine local guideline ( radiological T3a permit ) Serum PSA ≤15 Life expectancy ≥10 year Signed informed consent patient An understanding German language sufficient understand write verbal information trial consent process Men androgen suppression/hormone treatment within previous 12 month prostate cancer Men evidence metastatic disease nodal disease outside prostate bone scan crosssectional image Men inability tolerate transrectal ultrasound Men latex allergy HIFU probe cover latex condom sheath prior insertion back passage Men undergone prior significant rectal surgery prevent insertion transrectal HIFU probe ( decide type surgery individual case ) Men previous HIFU , cryosurgery , thermal microwave therapy prostate . Men undergone Transurethral Resection Prostate ( TURP ) symptomatic low urinary tract symptom within 6 month . These patient may include within trial defer consent screen least 6 month follow TURP . Men fit major surgery assess Consultant Anaesthetist Men unable pelvic MRI scanning ( severe claustrophobia , permanent cardiac pacemaker , metallic implant etc likely contribute significant artefact image ) Presence metal implants/stents urethra Presence prostatic calcification cyst ( transrectal ultrasound ) whose location interfere effective delivery HIFU therapy Men renal impairment glomerular filtration rate &lt; 35ml/min ( unable tolerate Gadolinium dynamic contrast enhance MRI ) .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>